Trial
NCT01987960
Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
H. Lundbeck A/S
Collaborators
Otsuka Pharmaceutical Co., Ltd.
Condition
Post-traumatic Stress Disorder
Intervention
Placebo
Why stopped
The study was terminated due to challenges with patient eligibility; the decision to terminate was not based on any safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-13